Pricing & Market Access

We are able to optimize pricing and access strategy through the close integration of product goals and strategies, with the realities of market-specific evidence requirements, payer goals, and competitive threats.

Our fundamentals as strategy consultants, paired with deep expertise in pricing, access, and evidence planning, uniquely position us to help our clients navigate global P&MA environments. We provide detailed, market-specific insights and P&MA strategies, and link them to broader commercial goals. This mix of P&MA and broader commercial expertise allows us to serve our clients’ market access, clinical, and commercial experts.

We work across all key major and emerging markets, providing strategic support in launch price setting and adjustments, launch sequencing, competitive entry strategy, contracting strategy, and evidence generation strategies, tailored to each market.

Our wide-ranging capabilities, deep expertise, and strategic background allow us to provide best-in-class support for P&MA challenges.

Project Types

Market Access Strategy

U.S. and Global P&MA Landscape Assessments

Global Launch Strategy, Sequencing, and Prioritization

Disruptive Trends Analysis

Framework Development

Indication Sequencing

Portfolio P&MA Strategy and Positioning

Pricing and Reimbursement

Early Pricing Strategy

Launch Pricing

Life Cycle Management Pricing

Innovative Pricing and Contracting Strategy

Contract Modelling

Gross-to-net Forecasting

Price and Revenue Optimization Models

Diligence Support

P&MA Due Diligence

Assumption Pressure Testing

Value and Evidence

Integrated HTA and Payer Evidence Planning

Payer Value Proposition Development

Value Driver Analysis

Case Studies

Let's talk about what we can accomplish together.

Pricing & Market Access Insights